Effector Therapeutics Inc (EFTR) — Cash Flow Reinvestment Rate
Effector Therapeutics Inc (EFTR) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $11.98 Million. Explore EFTR capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Effector Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Effector Therapeutics Inc across 1 annual periods. Also explore how large is Effector Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Effector Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Effector Therapeutics Inc. For live market cap and broader valuation context, see EFTR market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.02x | $308.00K | $13.84 Million | $154.00K | — |